Current Environment:

Summary

The purpose of the study is to characterize the clinical course of homocystinuria in pediatric and adult patients aged 5 to 65 years under current clinical management practices

Conditions

Homocystinuria Due to CBS Deficiency

Recruitment Status

Recruiting

Eligibility Criteria

Inclusion Criteria:

Patients who are clinically diagnosed with homocystinuria
Male/female patients aged 5 to 65 years
Patients who consented and/or assented
Patients who are willing and able to comply with all study-related procedures.

Exclusion Criteria:

Medically significant postnatal complications or congenital anomalies that are not associated with homocystinuria
Received any experimental therapy for homocystinuria during the 6 months prior to enrollment or expected to receive any such therapy during duration of the study

Gender

All

Minimum Age

5 Years

Maximum Age

65 Years

Download Date

February 4, 2022

Principal Investigator

N/A

Primary Contact Information

Travere Call Center

1-877-659-5518

medinfo@travere.com

For more information on this trial, visit clinicaltrials.gov.

Contact

For more information and to contact the study team: